Immuneering Corporation - Class A Common Stock — Cash Flow (NASDAQ:IMRX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -30.85 M-44.1 M-48.97 M-55 M-45.34 M -49.7 M Cash from investing activities -75.62 M41.83 M7.3 M26.43 M-88.74 M -151.8 M Cash from financing activities 144.26 M19 K28.44 M5.3 M226.58 M 212.95 M Free cash flow -30.85 M-44.1 M-48.97 M-55 M-45.49 M -49.91 M

News

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts - TipRanks.com

Piper Sandler cuts Immuneering stock price target on launch timing

Oppenheimer reiterates Immuneering stock rating on pipeline progress

Immuneering’s (IMRX) chief business officer buys $24,990 in stock

Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55%

Alibaba, Costco among market cap stock movers on Thursday

Costco, Alibaba among market cap stock movers on Thursday

Dow Jumps Over 250 Points; US Initial Jobless Claims Increase - Acrivon Therapeutics (NASDAQ:ACRV), Cormedix (NASDAQ:CRMD)

Nasdaq Falls Over 100 Points; Acuity Posts Upbeat Earnings - Acrivon Therapeutics (NASDAQ:ACRV), Acuity (NYSE:AYI)

Why Is Immuneering Stock Trading Lower Today? - Immuneering (NASDAQ:IMRX)